Life Science REIT PLC (LABS) — Strategic Asset Allocation Index
Life Science REIT PLC (LABS) has a Strategic Asset Allocation Index of 0.9% as of December 2024. Strategic assets (PP&E of GBX- plus long-term investments of GBX2.38 Million) total GBX2.38 Million, measured against net assets of GBX262.77 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Life Science REIT PLC Strategic Asset Allocation Index (2021–2024)
This chart shows how Life Science REIT PLC's Strategic Asset Allocation Index has evolved across 4 annual periods from 2021 to 2024. As of December 2024, the index stands at 0.9%, representing strategic assets of GBX2.38 Million against net assets of GBX262.77 Million GBX. See financial agility of Life Science REIT PLC to measure the company's free cash flow as a share of total liabilities.
Annual Strategic Asset Allocation Index for Life Science REIT PLC (2021–2024)
The table below presents the year-by-year Strategic Asset Allocation Index for Life Science REIT PLC from 2021 to 2024, covering 4 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see LABS market cap overview.
| Year | SAAI | Strategic Assets (GBX) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 0.9% | GBX2.38 Million | GBX- | GBX2.38 Million | GBX262.77 Million | ▼ -0.5 pp |
| 2023 | 1.4% | GBX4.00 Million | GBX- | GBX4.00 Million | GBX283.75 Million | ▲ +0.1 pp |
| 2022 | 1.3% | GBX4.30 Million | GBX- | GBX4.30 Million | GBX319.45 Million | ▼ -53.5 pp |
| 2021 | 54.8% | GBX192.17 Million | GBX192.17 Million | GBX- | GBX350.58 Million | — |